More on: Aspirin resistance [8]

Journal of Thrombosis and Haemostasis

Volumn 2, Issue 8, 2004, Pages 1489-

  Szczeklik, Andrzej ^a   Undas, A ^a  

^a JAGIELLONIAN UNIVERSITY MEDICAL COLLEGE   (Poland)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; BLOOD CLOTTING FACTOR 8; GLYCOPROTEIN IIIA; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; LEUCINE; THROMBIN; THROMBOPLASTIN; THROMBOXANE A2; VALINE; BETA3 INTEGRIN; BLOOD CLOTTING FACTOR 13; FIBRINOLYTIC AGENT;

ANTICOAGULATION; ATHEROSCLEROSIS; CARDIOVASCULAR DISEASE; DISEASE RESISTANCE; DRUG EFFICACY; DRUG SENSITIVITY; ENZYME INHIBITION; GENETIC POLYMORPHISM; HEREDITY; HUMAN; HYPERCHOLESTEROLEMIA; HYPERCOAGULABILITY; LETTER; LONG TERM CARE; PRIORITY JOURNAL; PROTEIN SYNTHESIS; RISK REDUCTION; THROMBOCYTE AGGREGATION; THROMBOEMBOLISM; ALLELE; DRUG RESISTANCE; GENETICS; GENOTYPE; HEART INFARCTION; METABOLISM; NOTE;

ALLELES; ASPIRIN; DRUG RESISTANCE; FACTOR XIII; FIBRINOLYTIC AGENTS; GENOTYPE; HUMANS; HYPERCHOLESTEROLEMIA; INTEGRIN BETA3; MYOCARDIAL INFARCTION; POLYMORPHISM, GENETIC; THROMBIN;

EID: 16644400297     PISSN: 15387933     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1538-7836.2004.00815.x     Document Type: Letter

References (12)

1. De Gaetano G, Cerletti C. Aspirin resistance: a revival of platelet aggregation tests? J Thromb Haemost 2003; 1: 2048-50.
2. Patrono C. Aspirin resistance: definition, mechanisms and clinical read-outs. J Thromb Haemost 2003; 1: 1710-13.
3. Szczeklik A, Musial J, Undas A, Sanak M, Dropinski J, Tuleja E, Wegrzyn W. Aspirin and thrombinogenesis. Thromb Res 2003; 110 345-7.
4. Jilma B, Fuchs J, Violi F, Pignatelli P, Pulcinelli FM. Forum on Aspirin. J Thromb Haemost 2004 2: 335-41.
5. Szczeklik A, Musial J, Undas A, Swadzba J, Gora PF, Piwowarska W, Duplaga M. Inhibition of thrombin generation by aspirin is blunted in hypercholesterolemia. Arterioscler Thromb Vasc Biol 1996; 16: 948-54.
6. Szczeklik A, Musial J, Undas A, Gajewski P, Gora P, Swadzba J, Jankowski M. Inhibition of thrombin generation by simvastatin and lack of additive effects of aspirin in patients with marked hypercholesterolemia. J Am Coll Cardiol 1999; 33: 1286-93.
7. Undas A, Brummel KE, Musial J, Mann KG, Szczeklik A. Simvastatin depresses blood clotting by inhibiting activation of prothrombin, factor V, and factor XIII and by enhancing factor Va inactivation. Circulation, 2001; 103: 2248-53.
8. Szczeklik A, Dropinski J, Radwan J, Krzanowski M. Persistent generation of thrombin after acute myocardial infarction. Arterioscler Thromb 1992; 12: 548-53.
9. Merlini PA, Bauer KA, Oltrona L, Ardissino D, Cattaneo M, Belli C, Mannucci PM, Rosenberg RD. Persistent activation of coagulation mechanism in unstable angina and myocardial infarction. Circulation 1994; 90: 61-8.
10. Szczeklik A, Undas A, Sanak M, Frolow M, Wegrzyn W. Relationship between bleeding time, aspirin and the P1A1/A2 polymorphism of platelet glycoprotein IIIa. Br J Haematol 2000; 110: 965-7.
11. Undas A, Brummel K, Musial J, Mann KG, Szczeklik A. P1(A2) polymorphism of beta(3) integrins is associated with enhanced thrombin generation and impaired antithrombotic action of aspirin at the site of microvascular injury. Circulation 2001; 104: 2666-72.
12. Undas A, Sydor WJ, Brummel K, Musial J, Mann KG, Szczeklik A. Aspirin alters the cardioprotective effects of the factor XIII Val34Leu polymorphism. Circulation 2003; 107: 17-20.